Files
Download (731 KB)
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston
Keywords
Endometrial Cancer; Everolimus; Progesterone; Levonorgestrel
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Program Affiliation
Partnership for Careers in Cancer Science and Medicine
Recommended Citation
Flores Barrera, Ernesto Saul; Alvarado, Tina; Granda, Gaby; Hull, Sara; Meyer, Larissa A.; Yates, Melinda; and Westin, Shannon N., "LEVER Trial: Levonorgestrel Intrauterine Device Alone or in Combination with an mTORC1 Inhibitor to Overcome Progesterone Resistance in Atypical Hyperplasia or Stage Ia Grade 1 Endometrioid Endometrial Cancer" (2021). Summer Experience 2021. 79.
https://openworks.mdanderson.org/sumexp21/79
Accessibility Statement
This item was created prior to May 2026. It is preserved for research, reference, or historical recordkeeping. Following WCAG 2.1, the library may provide accessible versions of archival materials upon request. For accommodation requests please submit an accessibility request form.
